Baidu
map

全国多省份取消公立医院医用耗材加成,滥用高值耗材将受严惩

2019-11-14 张尼 中新网客户端

日前,山东省政府召开常务会,审议通过《关于取消公立医疗机构医用耗材加成调整医疗服务价格的指导意见》。截至目前,全国已经有包括山东、福建、安徽、天津、北京、贵州、湖北、广东等多省份宣布取消医用耗材加成。根据国办印发的文件,2019年底前要实现全部公立医疗机构医用耗材“零差率”销售。与此同时,高值耗材滥用也将面临处罚。多省份发文取消公立医院医用耗材加成11日,山东省政府召开常务会,审议通过《关于取消公

日前,山东省政府召开常务会,审议通过《关于取消公立医疗机构医用耗材加成调整医疗服务价格的指导意见》。

截至目前,全国已经有包括山东、福建、安徽、天津、北京、贵州、湖北、广东等多省份宣布取消医用耗材加成。根据国办印发的文件,2019年底前要实现全部公立医疗机构医用耗材“零差率”销售。与此同时,高值耗材滥用也将面临处罚。

多省份发文取消公立医院医用耗材加成

11日,山东省政府召开常务会,审议通过《关于取消公立医疗机构医用耗材加成调整医疗服务价格的指导意见》。

《意见》明确,将全面取消全省各级各类公立医疗机构医用耗材加成,所有允许单独向患者收费的医用耗材,以实际购进价格实行“零差率”销售。新政自2019年12月10日开始实施。

据不完全统计,截至目前,全国已有山东、福建、安徽、天津、北京、贵州、湖北、广东等多省份宣布取消医用耗材加成。其中,福建、天津、广东、四川、新疆、辽宁、北京等已全面启动取消医用耗材加成。

今年6月15日,北京医耗联动综合改革正式实施,全市近3700所医疗机构按医用耗材进价收费。在取消“以药养医”后,北京正式告别了“以耗养医”。

此后,8月1日起,浙江也正式实施《浙江省省级公立医院医疗服务价格改革方案》,合理调整医疗服务价格,同步强化价格、医保等相关政策衔接。

方案实施范围是在杭的13家省级公立医院,调整了11类、938项医疗服务项目价格,提高了偏低的技术劳务型医疗服务项目价格,降低了偏高的大型医用设备检查治疗和检验等价格。此外,还取消了可单独收费医用耗材加成政策,实行零差率销售。

此外,重庆也将在本月26日召开全面取消公立医疗机构医用耗材加成改革医疗服务项目价格调整听证会。

具体来看,方案对全市公立医疗机构取消医用耗材加成而减少的收入,通过调整1842项手术治疗类医疗服务项目价格进行补偿,包括手术类1743项、介入治疗类62项、中医手术类37项。资料图 苍雁 摄

年底前实现全部公立医疗机构医用耗材“零差率”销售

过去,高值医用耗材价格虚高、过度使用等问题一直饱受诟病,并为患者带来沉重的医疗费用负担。因此,降低耗材费用、遏制滥用也是公立医院改革的一个重要环节。

早在2016年,国家发改委就会同多个部门发出《关于印发推进医疗服务价格改革意见的通知》。

文件提出,各地要围绕公立医院综合改革,统筹考虑取消药品加成及当地政府补偿政策,同步调整医疗服务价格,重点降低大型医用设备检查治疗和检验等价格,提高诊疗、手术、康复、护理、中医等体现医务人员技术劳务价值的医疗服务价格。

此外,要在此基础上,通过规范诊疗行为,降低药品、耗材等费用腾出空间,动态调整医疗服务价格。

今年7月底,国务院办公厅印发《治理高值医用耗材改革方案》,明确提出要完善价格形成机制,降低高值医用耗材虚高价格。

为降低虚高价格,《方案》提出五条举措,包括统一编码体系和信息平台,实行医保准入和目录动态调整,完善分类集中采购办法,取消医用耗材加成,制定医保支付政策。

依照《方案》,2019年底前要实现全部公立医疗机构医用耗材“零差率”销售,高值医用耗材销售价格按采购价格执行。

这也就意味着,官方已经为医用耗材取消加成制定了时间表,带量采购也扩大到耗材领域。

高值医用耗材滥用将面临严惩

政策文件发布后,如何保障其有效落实是外界关注的焦点。

记者注意到,在《治理高值医用耗材改革方案》中,就已经明确提出要健全监督管理机制,严肃查处违法违规行为。

依照《方案》,公立医疗机构要建立高值医用耗材配送遴选机制,促进市场合理竞争;加强公立医疗机构党风廉政建设,严格落实“一岗双责”,强化部门联动加大违纪违法行为查处力度。

今年9月1日起,国家卫健委和国家中医药局联合发布的《医疗机构医用耗材管理办法(试行)》正式施行。
 
在采购方面,《办法》中特别强调,医用耗材采购实施统一管理,二级以上医疗机构应当指定具体部门作为医用耗材管理部门,其他科室或者部门不得从事采购活动。

此外,文件还明确,不得将医用耗材购用情况作为科室、人员经济分配的依据,不得在医用耗材购用工作中牟取不正当经济利益。

国家医保局方面此前也明确表态,要针对高值医用耗材价格虚高、过度使用等突出问题,采取多项具体措施应对。

这其中就包括要落实医疗卫生行业管理责任,完善临床诊疗规范和指南,加强手术跟台管理,建立院内准入遴选、点评和异常使用预警等机制;加强定点医疗机构行为管理,完善医保智能审核系统,建立黑名单制度。

一系列政策的出台,将保证患者基本医疗费用负担总体不增加的背景下,以更合理的收费机制,降低耗材使用费,提升医疗服务收入水平。

版权声明:
本网站所有内容来源注明为“梅斯医学”或“MedSci原创”的文字、图片和音视频资料,版权均属于梅斯医学所有。非经授权,任何媒体、网站或个人不得转载,授权转载时须注明来源为“梅斯医学”。其它来源的文章系转载文章,或“梅斯号”自媒体发布的文章,仅系出于传递更多信息之目的,本站仅负责审核内容合规,其内容不代表本站立场,本站不负责内容的准确性和版权。如果存在侵权、或不希望被转载的媒体或个人可与我们联系,我们将立即进行删除处理。
在此留言
评论区 (6)
#插入话题
  1. [GetPortalCommentsPageByObjectIdResponse(id=2004483, encodeId=0cd420044836d, content=<a href='/topic/show?id=6d0c804419c' target=_blank style='color:#2F92EE;'>#耗材加成#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=42, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=80441, encryptionId=6d0c804419c, topicName=耗材加成)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=6bcd409, createdName=xfpan12, createdTime=Sat May 02 04:40:00 CST 2020, time=2020-05-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1701590, encodeId=dfaf1e015901b, content=<a href='/topic/show?id=bedc665998e' target=_blank style='color:#2F92EE;'>#滥用#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=26, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=66599, encryptionId=bedc665998e, topicName=滥用)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=ea1030383785, createdName=zchen, createdTime=Tue Feb 25 07:40:00 CST 2020, time=2020-02-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1772023, encodeId=b2d31e72023c5, content=<a href='/topic/show?id=a70f10218197' target=_blank style='color:#2F92EE;'>#高值#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=30, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=102181, encryptionId=a70f10218197, topicName=高值)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=7f5e38357689, createdName=guguangxiang, createdTime=Sat Mar 21 08:40:00 CST 2020, time=2020-03-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1380175, encodeId=a9a413801e591, content=<a href='/topic/show?id=a61534e3861' target=_blank style='color:#2F92EE;'>#医用耗材#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=36, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=34738, encryptionId=a61534e3861, topicName=医用耗材)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=5494471, createdName=HNYYM, createdTime=Sat Nov 16 01:40:00 CST 2019, time=2019-11-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1484388, encodeId=2d1a14843884b, content=<a href='/topic/show?id=68f180433bc' target=_blank style='color:#2F92EE;'>#耗材#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=30, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=80433, encryptionId=68f180433bc, topicName=耗材)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=e8187964274, createdName=41514489@qq.com, createdTime=Sat Nov 16 01:40:00 CST 2019, time=2019-11-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=375273, encodeId=dcd13e52735d, content=学习了,不错的话题,非常精彩,受益非浅, beContent=null, objectType=article, channel=null, level=null, likeNumber=87, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=7b005228115, createdName=14794e5bm67(暂无昵称), createdTime=Fri Nov 15 18:34:54 CST 2019, time=2019-11-15, status=1, ipAttribution=)]
  2. [GetPortalCommentsPageByObjectIdResponse(id=2004483, encodeId=0cd420044836d, content=<a href='/topic/show?id=6d0c804419c' target=_blank style='color:#2F92EE;'>#耗材加成#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=42, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=80441, encryptionId=6d0c804419c, topicName=耗材加成)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=6bcd409, createdName=xfpan12, createdTime=Sat May 02 04:40:00 CST 2020, time=2020-05-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1701590, encodeId=dfaf1e015901b, content=<a href='/topic/show?id=bedc665998e' target=_blank style='color:#2F92EE;'>#滥用#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=26, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=66599, encryptionId=bedc665998e, topicName=滥用)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=ea1030383785, createdName=zchen, createdTime=Tue Feb 25 07:40:00 CST 2020, time=2020-02-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1772023, encodeId=b2d31e72023c5, content=<a href='/topic/show?id=a70f10218197' target=_blank style='color:#2F92EE;'>#高值#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=30, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=102181, encryptionId=a70f10218197, topicName=高值)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=7f5e38357689, createdName=guguangxiang, createdTime=Sat Mar 21 08:40:00 CST 2020, time=2020-03-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1380175, encodeId=a9a413801e591, content=<a href='/topic/show?id=a61534e3861' target=_blank style='color:#2F92EE;'>#医用耗材#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=36, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=34738, encryptionId=a61534e3861, topicName=医用耗材)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=5494471, createdName=HNYYM, createdTime=Sat Nov 16 01:40:00 CST 2019, time=2019-11-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1484388, encodeId=2d1a14843884b, content=<a href='/topic/show?id=68f180433bc' target=_blank style='color:#2F92EE;'>#耗材#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=30, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=80433, encryptionId=68f180433bc, topicName=耗材)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=e8187964274, createdName=41514489@qq.com, createdTime=Sat Nov 16 01:40:00 CST 2019, time=2019-11-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=375273, encodeId=dcd13e52735d, content=学习了,不错的话题,非常精彩,受益非浅, beContent=null, objectType=article, channel=null, level=null, likeNumber=87, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=7b005228115, createdName=14794e5bm67(暂无昵称), createdTime=Fri Nov 15 18:34:54 CST 2019, time=2019-11-15, status=1, ipAttribution=)]
    2020-02-25 zchen
  3. [GetPortalCommentsPageByObjectIdResponse(id=2004483, encodeId=0cd420044836d, content=<a href='/topic/show?id=6d0c804419c' target=_blank style='color:#2F92EE;'>#耗材加成#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=42, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=80441, encryptionId=6d0c804419c, topicName=耗材加成)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=6bcd409, createdName=xfpan12, createdTime=Sat May 02 04:40:00 CST 2020, time=2020-05-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1701590, encodeId=dfaf1e015901b, content=<a href='/topic/show?id=bedc665998e' target=_blank style='color:#2F92EE;'>#滥用#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=26, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=66599, encryptionId=bedc665998e, topicName=滥用)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=ea1030383785, createdName=zchen, createdTime=Tue Feb 25 07:40:00 CST 2020, time=2020-02-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1772023, encodeId=b2d31e72023c5, content=<a href='/topic/show?id=a70f10218197' target=_blank style='color:#2F92EE;'>#高值#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=30, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=102181, encryptionId=a70f10218197, topicName=高值)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=7f5e38357689, createdName=guguangxiang, createdTime=Sat Mar 21 08:40:00 CST 2020, time=2020-03-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1380175, encodeId=a9a413801e591, content=<a href='/topic/show?id=a61534e3861' target=_blank style='color:#2F92EE;'>#医用耗材#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=36, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=34738, encryptionId=a61534e3861, topicName=医用耗材)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=5494471, createdName=HNYYM, createdTime=Sat Nov 16 01:40:00 CST 2019, time=2019-11-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1484388, encodeId=2d1a14843884b, content=<a href='/topic/show?id=68f180433bc' target=_blank style='color:#2F92EE;'>#耗材#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=30, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=80433, encryptionId=68f180433bc, topicName=耗材)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=e8187964274, createdName=41514489@qq.com, createdTime=Sat Nov 16 01:40:00 CST 2019, time=2019-11-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=375273, encodeId=dcd13e52735d, content=学习了,不错的话题,非常精彩,受益非浅, beContent=null, objectType=article, channel=null, level=null, likeNumber=87, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=7b005228115, createdName=14794e5bm67(暂无昵称), createdTime=Fri Nov 15 18:34:54 CST 2019, time=2019-11-15, status=1, ipAttribution=)]
  4. [GetPortalCommentsPageByObjectIdResponse(id=2004483, encodeId=0cd420044836d, content=<a href='/topic/show?id=6d0c804419c' target=_blank style='color:#2F92EE;'>#耗材加成#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=42, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=80441, encryptionId=6d0c804419c, topicName=耗材加成)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=6bcd409, createdName=xfpan12, createdTime=Sat May 02 04:40:00 CST 2020, time=2020-05-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1701590, encodeId=dfaf1e015901b, content=<a href='/topic/show?id=bedc665998e' target=_blank style='color:#2F92EE;'>#滥用#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=26, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=66599, encryptionId=bedc665998e, topicName=滥用)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=ea1030383785, createdName=zchen, createdTime=Tue Feb 25 07:40:00 CST 2020, time=2020-02-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1772023, encodeId=b2d31e72023c5, content=<a href='/topic/show?id=a70f10218197' target=_blank style='color:#2F92EE;'>#高值#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=30, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=102181, encryptionId=a70f10218197, topicName=高值)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=7f5e38357689, createdName=guguangxiang, createdTime=Sat Mar 21 08:40:00 CST 2020, time=2020-03-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1380175, encodeId=a9a413801e591, content=<a href='/topic/show?id=a61534e3861' target=_blank style='color:#2F92EE;'>#医用耗材#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=36, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=34738, encryptionId=a61534e3861, topicName=医用耗材)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=5494471, createdName=HNYYM, createdTime=Sat Nov 16 01:40:00 CST 2019, time=2019-11-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1484388, encodeId=2d1a14843884b, content=<a href='/topic/show?id=68f180433bc' target=_blank style='color:#2F92EE;'>#耗材#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=30, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=80433, encryptionId=68f180433bc, topicName=耗材)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=e8187964274, createdName=41514489@qq.com, createdTime=Sat Nov 16 01:40:00 CST 2019, time=2019-11-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=375273, encodeId=dcd13e52735d, content=学习了,不错的话题,非常精彩,受益非浅, beContent=null, objectType=article, channel=null, level=null, likeNumber=87, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=7b005228115, createdName=14794e5bm67(暂无昵称), createdTime=Fri Nov 15 18:34:54 CST 2019, time=2019-11-15, status=1, ipAttribution=)]
  5. [GetPortalCommentsPageByObjectIdResponse(id=2004483, encodeId=0cd420044836d, content=<a href='/topic/show?id=6d0c804419c' target=_blank style='color:#2F92EE;'>#耗材加成#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=42, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=80441, encryptionId=6d0c804419c, topicName=耗材加成)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=6bcd409, createdName=xfpan12, createdTime=Sat May 02 04:40:00 CST 2020, time=2020-05-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1701590, encodeId=dfaf1e015901b, content=<a href='/topic/show?id=bedc665998e' target=_blank style='color:#2F92EE;'>#滥用#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=26, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=66599, encryptionId=bedc665998e, topicName=滥用)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=ea1030383785, createdName=zchen, createdTime=Tue Feb 25 07:40:00 CST 2020, time=2020-02-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1772023, encodeId=b2d31e72023c5, content=<a href='/topic/show?id=a70f10218197' target=_blank style='color:#2F92EE;'>#高值#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=30, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=102181, encryptionId=a70f10218197, topicName=高值)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=7f5e38357689, createdName=guguangxiang, createdTime=Sat Mar 21 08:40:00 CST 2020, time=2020-03-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1380175, encodeId=a9a413801e591, content=<a href='/topic/show?id=a61534e3861' target=_blank style='color:#2F92EE;'>#医用耗材#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=36, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=34738, encryptionId=a61534e3861, topicName=医用耗材)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=5494471, createdName=HNYYM, createdTime=Sat Nov 16 01:40:00 CST 2019, time=2019-11-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1484388, encodeId=2d1a14843884b, content=<a href='/topic/show?id=68f180433bc' target=_blank style='color:#2F92EE;'>#耗材#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=30, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=80433, encryptionId=68f180433bc, topicName=耗材)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=e8187964274, createdName=41514489@qq.com, createdTime=Sat Nov 16 01:40:00 CST 2019, time=2019-11-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=375273, encodeId=dcd13e52735d, content=学习了,不错的话题,非常精彩,受益非浅, beContent=null, objectType=article, channel=null, level=null, likeNumber=87, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=7b005228115, createdName=14794e5bm67(暂无昵称), createdTime=Fri Nov 15 18:34:54 CST 2019, time=2019-11-15, status=1, ipAttribution=)]
  6. [GetPortalCommentsPageByObjectIdResponse(id=2004483, encodeId=0cd420044836d, content=<a href='/topic/show?id=6d0c804419c' target=_blank style='color:#2F92EE;'>#耗材加成#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=42, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=80441, encryptionId=6d0c804419c, topicName=耗材加成)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=6bcd409, createdName=xfpan12, createdTime=Sat May 02 04:40:00 CST 2020, time=2020-05-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1701590, encodeId=dfaf1e015901b, content=<a href='/topic/show?id=bedc665998e' target=_blank style='color:#2F92EE;'>#滥用#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=26, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=66599, encryptionId=bedc665998e, topicName=滥用)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=ea1030383785, createdName=zchen, createdTime=Tue Feb 25 07:40:00 CST 2020, time=2020-02-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1772023, encodeId=b2d31e72023c5, content=<a href='/topic/show?id=a70f10218197' target=_blank style='color:#2F92EE;'>#高值#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=30, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=102181, encryptionId=a70f10218197, topicName=高值)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=7f5e38357689, createdName=guguangxiang, createdTime=Sat Mar 21 08:40:00 CST 2020, time=2020-03-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1380175, encodeId=a9a413801e591, content=<a href='/topic/show?id=a61534e3861' target=_blank style='color:#2F92EE;'>#医用耗材#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=36, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=34738, encryptionId=a61534e3861, topicName=医用耗材)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=5494471, createdName=HNYYM, createdTime=Sat Nov 16 01:40:00 CST 2019, time=2019-11-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1484388, encodeId=2d1a14843884b, content=<a href='/topic/show?id=68f180433bc' target=_blank style='color:#2F92EE;'>#耗材#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=30, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=80433, encryptionId=68f180433bc, topicName=耗材)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=e8187964274, createdName=41514489@qq.com, createdTime=Sat Nov 16 01:40:00 CST 2019, time=2019-11-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=375273, encodeId=dcd13e52735d, content=学习了,不错的话题,非常精彩,受益非浅, beContent=null, objectType=article, channel=null, level=null, likeNumber=87, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=7b005228115, createdName=14794e5bm67(暂无昵称), createdTime=Fri Nov 15 18:34:54 CST 2019, time=2019-11-15, status=1, ipAttribution=)]
    2019-11-15 14794e5bm67(暂无昵称)

    学习了,不错的话题,非常精彩,受益非浅

    0

相关资讯

高值医用耗材带量采购即将启动!所有公立医院集采行为受限

继药品之后,高值医用耗材的全面治理行动终于拉开大幕。7月31日,业内期盼已久的《治理高值医用耗材改革方案》(下称《方案》)由国务院正式对外公布。对于文件中部署的4方面重点工作,在8月1日国务院举行的政策例行吹风会上,国家医疗保障局(下称国家医保局)副局长李滔用“促降价、防滥用、严监管、助发展”精准概括。虽短短12个字,但其背后诸多改革措施还亟待完善,且需要多部门共同发力。《方案》中,“要按照带量采

构建健康生态命运共同体,公立医院转型正当时

关于医院的发展趋势,从2018年以来,大家说的比较多的、比较官方的表达方式是,中国医院规模化发展将进入尾声,正进入质量化转型阶段。我想说的是,这是从医院角度出发而言的一种说法,如果从整个卫生健康生态体系出发,说得比较尖锐一点,就是大型公立医院尤其是要从掠夺式发展转变成共享式发展,要按照国家要求做好对下级医院的帮扶,构建起与下级医院的发展命运共同体,建设好共同发展的本地卫生健康医疗新生态。公立医院发

一批医生集团发展缓慢,几大因素曝光

从目前看,医生集团的发展缓慢,总体无非几大因素:医生还未能真正开展自由执业(这里不仅指外部环境,还包括医生的观念),医生集团的发展受限于可以多点执业的医生数量;医生集团缺乏经营管理的人才,尤其是具备市场观念的经营管理人才;医生集团普遍存在不同程度的获客难题。

深圳公立医院成“二级体系” 其他地区能复制吗?

6月24日,深圳市卫健委发布了《关于深入推进优质高效的整合型医疗卫生服务体系建设的实施意见》(以下简称《意见》),应该说是这“十三五”末深圳医改的“收官之作”,也是落实分级诊疗方面的制度性举措,可以称得上“罗湖模式”的“深圳版本”。实现“市-区”二级分诊体系,明确各自功能定位,特别是对之做强社康中心、做实家庭医生服务有重要的实践意义。从实践探索来看,对于全国推广似乎仍然需要实践进一步验证。“权

公立医院特需医疗:是大小通吃的尴尬还是顺应民意的产物?

这么多年过去了,曾诺还是忘记不了那517元。6年前怀孕时,因为胎儿心脏不好看过一次特需门诊,曾诺就对那次经历念念不忘:乘电梯到达医院门诊部顶层,与下面的嘈杂截然不同,这里一切看上去安静干净,患者脸上似乎少了疾病留下的狰狞苦痛。走进一间宽敞而独立的诊室,里面摆放着一张电脑桌,桌子前面有一老一少像师徒的两位白衣大夫,年长的医生轻声细语得对曾诺说:“请坐”。“我当时急得至少问了20个以上的问题,他都

49家医疗机构上“黑榜”2019上半年触红线机构一览

2019年8月底,上海卫健委监督所通报了 2019上半年医疗机构违法广告。有49家医疗机构因医疗广告违法受到行政处罚。

Baidu
map
Baidu
map
Baidu
map